SciThera
SciThera is a biotech company in San Diego, United States. It has raised $26.0M across 1 round, most recently a $26.0M Seed in 2025 (est.).
- Headquarters
- San Diego, California
- Business Model
- B2B
- Website
- scithera.bio
- Total Funding
- $26.0M
- Last Round
- $26.0M SeedJan 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
SciThera, Inc. is a San Diego, California-based biotechnology company focused on discovering and developing novel antibody-based therapeutics, including antibody-drug conjugates, for the treatment of cancer. According to an SEC filing by Inhibrx, SciThera is a newly formed biotechnology company that focuses on antibody-based molecules and has entered into a licensing agreement with Inhibrx. SciThera is backed by venture capital firm Venrock and led by CEO Brendan Eckelman.
Summary
It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in 2025 (est.). Investors include Venrock.
Funding History
2025 (est.)
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/scithera"><img src="https://indexed.vc/api/badge/company/scithera" alt="SciThera on Indexed.vc" width="260" height="76" /></a>
